Search Results - Phatak H
- Showing 1 - 4 results of 4
-
1
Budget impact model of avelumab in patients with metastatic merkel cell carcinoma in the US by Bharmal M, Kearney M, Zheng Y, Phatak H
Published 2019Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Clinical Outcomes, Costs, and Healthcare Resource Utilization in Patients with Metastatic Merkel Cell Carcinoma Treated with Immune Checkpoint Inhibitors vs Chemotherapy by Zheng Y, Yu T, Mackey RH, Gayle JA, Wassel CL, Phatak H, Kim R
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
Budget Impact Of Including Avelumab As A Second-Line Treatment For Locally Advanced Or Metastatic Urothelial Cancer In The United States: Commercial And Medicare Payer Perspectives by Kongnakorn T, Bharmal M, Kearney M, Phatak H, Benedict A, Bhanegaonkar A, Galsky M
Published 2019Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
4
Treatment Sequencing Patterns in Patients with Metastatic Urothelial Cancer Treated in the Community Practice Setting in the United States: SPEAR-Bladder (Study informing treatment... by Doshi GK, Bhanegaonkar A, Kearney M, Bharmal M, Cislo P, Kim R, Boyd M, Aguilar KM, Phatak H
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book